Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pro Medicus Limited ( (AU:PME) ) has issued an announcement.
Pro Medicus Limited announced a change in the director’s interest in securities, with Director Alice Williams acquiring 125 ordinary shares at a value of $272.69 each. This change highlights the director’s increased stake in the company, potentially signaling confidence in the company’s future performance and stability. The acquisition brings Williams’ total holdings to 2,185 shares, indicating a strategic move that might influence stakeholders’ perceptions of the company’s market positioning.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, offering advanced imaging and informatics solutions primarily for the medical field. The company is focused on providing innovative software products that enhance diagnostic imaging, catering to a global market of hospitals, imaging centers, and healthcare practitioners.
YTD Price Performance: 11.44%
Average Trading Volume: 350
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $18.92B
For an in-depth examination of PME stock, go to TipRanks’ Stock Analysis page.
